Table 1 Characteristics of the study subjects (n = 258)
Variable | Mean (SD), n | Variable | Mean (SD), n | |
|---|---|---|---|---|
Age (years) | 70.05 ± 8.95 | Smoking (0/1/2a) | 243/13/2 | |
Age of menopause (years) | 50.44 ± 2.22 | Tea (0/1/2a) | 243/15/0 | |
BMI (kg/m2) | 24.00 ± 3.07 | Coffee (0/1/2a) | 246/11/1 | |
Previous osteoporosis fracture (yes/no) | 174/84 | Alcohol (0/1/2/3a) | 243/14/1/0 | |
Gastrointestinal disease (yes/no) | 24/234 | Diet pattern | Mediterranean | 76 |
Hypertension (yes/no) | 80/178 | Western | 57 | |
Diabetes (yes/no) | 31/227 | Asian | 96 | |
Bisphosphonates (yes/no) | 15/243 | Vegetarian | 29 | |
Glucocorticoid (yes/no) | 28/230 | Exercise (1/2/3/4b) | 37/143/67/11 | |
Menatetrenone/Vit K2 (yes/no) | 32/226 | ALT (U/L) | 26.25 ± 11.76 | |
25(OH)D level at baseline (ng/ml) | 20.33 ± 7.18 | AST (U/L) | 28.78 ± 10 | |
PINP level at baseline (ng/ml) | 63.46 ± 22.66 | TG (mmol/L) | 4.72 ± 1.1 | |
β-CTX level at baseline(ng/ml) | 0.65 ± 0.26 | UA (umol/L) | 228.88 ± 80.4 | |
PINP increment (3 month) | 74.75 ± 54.90 | Creatine (umol/L) | 72.27 ± 17 | |
β-CTX increment (3 month) | 0.22 ± 0.31 | LS BMD at baseline | -3.3 ± 0.93 | |